Vaxxas, a clinical-stage biotech company commercializing new vaccine platform technology, today announced the opening of its first state-of-the-art manufacturing facility in Brisbane, Queensland. The purpose-built 5,500-square-foot (60,000 square foot) Vaxxas Biomedical Facility will serve as the company’s global headquarters and support its expansion to produce HD-MAP vaccines for prospective late-stage […]
Featured News
TheMathCompany Partners with Komodo Health to Enhance Patient Outcomes with Advanced Insights
TheMathCompany, based in Illinois, a leading global data analytics and engineering company, announced a partnership with health technology company, Komodo Health. Through this partnership, TheMathCompany will have access to Komodo’s technology platform, powered by Healthcare Map – the most comprehensive and accurate source of anonymous patient-level data available – to […]
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
Ironwood Pharmaceuticals, Inc., a gastrointestinalfocused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved LINZESS® (linaclotide) as a method of treatment. once-daily treatment of dysfunctional pediatric patients 6 to 17 years of age. constipation. LINZESS is the first and only FDA-approved prescription treatment for functional […]
Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship
Allergan Aesthetics, the maker of onabotulinumtoxinA (Botox), has partnered with IFundWomen to ensure women entrepreneurs can apply for $25,000 funding, coaching and mentoring. The partnership, announced on International Women’s Day (March 8), aims to fill a gap in the beliefs of rising women. Allergan Aesthetics leaders say they are committed […]
Clean Cells begins activities in the largest biopharmaceutical testing site in Europe
Clean Cells has launched analytical operations at its new €22 million ($24.1 million) plant based in Montaigu-Vendée. Clean Cells is part of the Clean Biologics Group, a supplier of quality control services to biopharmaceuticals and manufacturers of raw materials. The site offers four times more lab space than the previous […]
GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare announced today at the European Congress of Radiology (ECR) in Vienna, Austria that it has completed the registration of Phase I subjects in the initial clinical development program for circumferential magnetic resonance imaging. Manganese-based large-scale, the first contrast agent of its kind (MRI). agency. Typically, MRI agents – […]
Ascelia Pharma Meets Major Milestone With Patient Enrollment Completion For Orviglance Phase 3 Study, Sparkle
Ascelia Pharma AB, a biotech company focused on improving the lives of people with rare cancers, today announced the successful completion of patient enrollment in a clinical study. SPARKLE’s Phase 3 clinical trial with the main drug candidate Orviglance. “We are very pleased to have reached our enrollment target of […]
OCD-focused platform NOCD raises $35M and more digital health fundings
Digital obsessive-compulsive disorder (OCD) identification and management platform NOCD has closed a $35 million funding round co-led by Cigna Ventures and 7wireVentures. Existing investors F-Prime Capital, Kaiser Permanente Ventures, Health Enterprise Partners and Eight Roads Capital also participated in the round along with new investor Longitude Capital. The Chicago-based company […]
Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.
Premier Inc., a renowned healthcare improvement firm running one of the biggest group purchasing organisations in the country, has awarded a group purchasing deal to Ritedose, a 503B outsourcing plant in South Carolina (GPOs). With effect from January 1, 2023, the new arrangement enables Premier members to choose whether to […]
Abbott Receives Approval From Anvisa For Ultreon™, Imaging Technology That Uses Artificial Intelligence For Coronary Arteries
The National Health Surveillance Agency (Anvisa) recently gave its latest optical coherence tomography (OCT) imaging platform with the new UltreonTM Software its seal of approval, according to Abbott. In order to give clinicians an expanded, comprehensive image of coronary blood flow and blockages to support clinical decision-making and provide the […]
